Comorbidity between Behavioral Addictions and Attention Deficit/Hyperactivity Disorder: a Systematic Review
- 814 Downloads
We aimed to conduct a systematic review to examine the rates of comorbid Attention Deficit/Hyperactivity Disorder (ADHD) and various behavioral addictions, including gambling disorder, food addiction/binge-eating disorder, sex addiction/hypersexuality disorder, Internet addiction/Internet gaming disorder, compulsive buying disorder, and exercise addiction. PubMed and Web of Science were searched for articles published before December, 2015. Exclusion criteria were studies with either behavioral addictions or ADHD only, but not both; review articles, case reports, case series, book chapters, and letters to the editor. Studies not using standardized diagnostic criteria for ADHD, gambling disorder, or binge-eating disorder were also excluded. Of the 3126 citations found, 14 studies fulfilled the inclusion criteria. Five reported results for rates of comorbid ADHD and gambling disorder, three for those of ADHD and binge-eating disorder, two for those of ADHD and sex addiction, and four for those of ADHD and Internet addiction. No studies were found to report rates of comorbid ADHD and compulsive buying disorder or exercise addiction. The prevalence of comorbid ADHD in individuals with behavioral addictions ranged from 5.8 % to 88.3 %. The prevalence of comorbid behavioral addictions in those with ADHD ranged from 5.9 % to 71.8 %. This systematic review revealed a high degree of co-occurrence of ADHD and behavioral addictions. The findings of this review shed light on the need to explore the links between ADHD and behavioral addictions and their implications for treatment.
KeywordsADHD Behavioral addictions Comorbidity Systematic review
Compliance with Ethical Standards
Conflicts of Interest
Authors Servet Karaca, Ayman Saleh, Fatih Canan and Marc N. Potenza declare that they have no conflict of interest. Author Marc N. Potenza has received financial support or compensation for the following: Dr. Potenza has consulted for and advised Boehringer Ingelheim, Ironwood, Lundbeck, INSYS, Shire, RiverMend Health and Opiant/Lakelight Therapeutics; has received research support from the NIH, Veteran’s Administration, Mohegan Sun Casino, the National Center for Responsible Gaming, and Pfizer, Forest Laboratories, Ortho-McNeil, Psyadon, Oy-Control/Biotie and Glaxo-SmithKline pharmaceuticals; has participated in surveys, mailings or telephone consultations related to drug addiction, impulse control disorders or other health topics; has consulted for law offices and the federal public defender’s office in issues related to impulse control disorders; provides clinical care in the Connecticut Department of Mental Health and Addiction Services Problem Gambling Services Program; has performed grant reviews for the NIH and other agencies; has edited journals and journal sections; has given academic lectures in grand rounds, CME events and other clinical or scientific venues; and has generated books or book chapters for publishers of mental health texts.
Author Marc N. Potenza received support from the National Center for Responsible Gaming and CASAColumbia. The contents of the manuscript are solely the responsibility of the authors and do not necessarily represent the official view of any of the funding agencies.
No animal or human studies were carried out by the authors for this article.
- Arias, A. J., Gelernter, J., Chan, G., Weiss, R. D., Brady, K. T., Farrer, L., et al. (2008). Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addictive Behaviors, 33, 1199–1207.PubMedPubMedCentralCrossRefGoogle Scholar
- American Psychiatric Association (1987). Diagnostic and statistical manual of mental disorders revised (3rd ed.). Washington, DC: American Psychiatric Association.Google Scholar
- American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders. 4th text (revised ed.). Washington, DC: American Psychiatric Association.Google Scholar
- Biederman, J., Wilens, T., Mick, E., Milberger, S., Spencer, T. J., & Faraone, S. V. (1995). Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. The American Journal of Psychiatry, 152, 1652–1658.PubMedCrossRefGoogle Scholar
- Black, D. W., Repertinger, S., Gaffney, G. R., & Et Al. (1998). Family history and psychiatric comorbidity in persons with compulsive buying. American Journal of Psychiatry, 155, 960–963.Google Scholar
- Bloch, M. H., & Qawasmi, A. (2011). Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 50, 991–1000.PubMedPubMedCentralCrossRefGoogle Scholar
- Brod, M., Johnston, J., Able, S., & Swindle, R. (2006). Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale (AAQoL): a disease-specific quality-of-life measure. Quality of Life Research: an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 15, 117–129.CrossRefGoogle Scholar
- Comings, D. E., Gonzalez, N., Wu, S., Gade, R., Muhleman, D., Saucier, G., et al. (1999). Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. American Journal of Medical Genetics, 88, 358–368.PubMedCrossRefGoogle Scholar
- Dittmar, H. (2005). Compulsive buying–a growing concern? An examination of gender, age, and endorsement of materialistic values as predictors. British Journal of Psychology (London, England : 1953), 96, 467–491.Google Scholar
- Fineberg, N. A., Chamberlain, S. R., Goudriaan, A. E., Stein, D. J., Vanderschuren, L. J. M. J., Gillan, C. M., et al. (2014). New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity. CNS Spectrums, 19, 69–89.PubMedPubMedCentralCrossRefGoogle Scholar
- Grant, J. E., Atmaca, M., Fineberg, N. A., Fontenelle, L. F., Matsunaga, H., Janardhan Reddy, Y. C., et al. (2014). Impulse control disorders and “behavioural addictions” in the ICD-11. World Psychiatry : Official Journal of the World Psychiatric Association (WPA), 13, 125–127.CrossRefGoogle Scholar
- Holden, C. (2001). “Behavioral” addictions: do they exist? Science (New York, N. Y.), 294, 980–982.Google Scholar
- Imperatori, C., Innamorati, M., Contardi, A., Continisio, M., Tamburello, S., Lamis, D. A., et al. (2014). The association among food addiction, binge eating severity and psychopathology in obese and overweight patients attending low-energy-diet therapy. Comprehensive Psychiatry, 55, 1358–1362.PubMedCrossRefGoogle Scholar
- Kaess, M., Durkee, T., Brunner, R., Carli, V., Parzer, P., Wasserman, C., et al. (2014). Pathological internet use among European adolescents: psychopathology and self-destructive behaviours. European Child & Adolescent Psychiatry, 1093–1102.Google Scholar
- Kafka, M. P., & Hennen, J. (2002). A DSM-IV Axis I comorbidity study of males (n = 120) with paraphilias and paraphilia-related disorders. Sexual Abuse : A Journal of Research and Treatment, 14, 349–366.Google Scholar
- Levy, L. D., Fleming, J. P., & Klar, D. (2009). Treatment of refractory obesity in severely obese adults following management of newly diagnosed attention deficit hyperactivity disorder. International Journal of Obesity, 33, 326–334.Google Scholar
- McElroy, S. L., Hudson, J. I., Mitchell, J. E., Wilfley, D., Ferreira-Cornwell, M. C., Gao, J., et al. (2015). Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial. JAMA Psychiatry, 72, 235–246.PubMedCrossRefGoogle Scholar
- Müller, A., Mitchell, J. E., & de Zwaan, M. (2013). Compulsive buying. The American Journal on Addictions, 1–6. doi: 10.1111/j.1521-0391.2013.12111.x.
- Potenza, M. N. (2006). Should addictive disorders include non-substance-related conditions? Addiction (Abingdon, England), 101, 142–151.Google Scholar
- Reinblatt, S. P., Leoutsakos, J.-M. S., Mahone, E. M., Forrester, S., Wilcox, H. C., & Riddle, M. A. (2015). Association between binge eating and attention-deficit/hyperactivity disorder in two pediatric community mental health clinics. The International Journal of Eating Disorders, 48, 505–511.PubMedCrossRefGoogle Scholar
- Sagvolden, T., Johansen, E. B., Aase, H., & Russell, V. A. (2005). A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. The Behavioral and Brain Sciences, 28, 397–419 discussion 419–468.PubMedCrossRefGoogle Scholar
- Sarver, D. E., McCart, M. R., Sheidow, A. J., & Letourneau, E. J. (2014). ADHD and risky sexual behavior in adolescents: conduct problems and substance use as mediators of risk. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 55, 1345–1353.PubMedPubMedCentralCrossRefGoogle Scholar
- Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., et al. (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA, 283, 2008–2012.PubMedCrossRefGoogle Scholar
- Sullivan, M. A., & Rudnik-Levin, F. (2001). Attention deficit/hyperactivity disorder and substance abuse - diagnostic and therapeutic considerations. Adult Attention Deficit Disorder, 931, 251–270.Google Scholar
- van Emmerik-van Oortmerssen, K., van de Glind, G., van den Brink, W., Smit, F., Crunelle, C. L., Swets, M., et al. (2012). Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug and Alcohol Dependence, 122, 11–19.PubMedCrossRefGoogle Scholar
- Willcutt, E. G., Nigg, J. T., Pennington, B. F., Solanto, M. V, Rohde, L. A., Tannock, R., Loo, S. K., Carlson, C. L., McBurnett, K., & Lahey, B. B. (2012). Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes. Journal of Abnormal Psychology, 121, 991–1010.Google Scholar
- World Health Organization (2007). International classification of diseases (10th ed.). Geneva: World Health Organization.Google Scholar
- Zwi, M., Jones, H., Thorgaard, C., York, A., & Dennis, J. A. (2011). Parent training interventions for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years. The Cochrane Database of Systematic Reviews, 12, CD003018.Google Scholar